New anticancer treatment

10 currently open clinical trials

Combined therapy for mantle cell lymphoma
SAKK 36/13
Safety and tolerability of a combination of obinutuzumab and venetoclax in patients with advanced follicular lymphoma
SAKK 35/15
Radio-chemotherapy improvement for locally advanced rectal cancer
SAKK 41/16
Dosage of a new targeted drug for the treatment of lung cancer
SAKK 19/16
A phase I trial with TLD-1, a novel liposomal doxorubicin, in patients with advanced solid tumors
SAKK 65/16
Stimulating the immune system to fight against squamous cell carcinoma
SAKK 11/16
NAPAGE: Nab-paclitaxel and gemcitabine for advanced soft tissue sarcomas
SAKK 57/16
Determination of the maximum tolerated dose of a new Microtubule Targeting Agent on adult patients with a recurrent solid tumor
SAKK 67/15
A phase I study of LY3200882 in patients with solid tumors (oral TGFβ inhibitor)
SAKK 68/17
Studie mit dem ATR Inhibitor BAY-1895344 bei Patienten mit fortgeschrittenen soliden Tumoren und Lymphomen (Erstanwendung beim Menschen)
SAKK 69/17
All cancer types